Physician profile
Ramon Kumar
NPI 1093030934
$1,907.35
in general payments reported to CMS, 2019-2025
18 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2021: $232 · 2022: $362 · 2023: $584 · 2024: $261 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,029.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $677.82 | 2019-2023 | Avvigo Guidance System, Wolverine Coronary Cutting Balloon |
| Cardiovascular Systems INC. | $190.26 | 2019-2023 | Diamondback Coronary, Diamondback Peripheral |
| Heartflow, INC. | $186.14 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $138.23 | 2019-2024 | |
| Bard Peripheral Vascular, INC. | $129.06 | 2023 | Venovo |
| Shockwave Medical, INC | $114.57 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $70.02 | 2019-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $63.98 | 2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $57.05 | 2023-2024 | Camzyos, Eliquis |
| Sanofi-Aventis U.S. LLC | $47.98 | 2019 | |
| Cleerly, INC. | $41.69 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Mindray Ds USA, INC. | $40.96 | 2024 | Te7 Max, Te X |
| Scpharmaceuticals INC. | $39.92 | 2025 | |
| Irhythm Technologies, INC. | $32.55 | 2019-2021 | |
| Pfizer INC. | $32.44 | 2019-2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $19.48 | 2024 | |
| Siemens Medical Solutions USA, INC. | $14.23 | 2023 | Artis Icono Biplane |
| Boehringer Ingelheim Pharmaceuticals, INC. | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramon Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.